Source: BioSpace

Nuvo Pharmaceuticals: Nuvo Pharmaceuticals Announces First Quarter 2020 Results Release Date and Virtual Annual & Special Meeting of Shareholders

Nuvo Pharmaceuticals Inc. (Nuvo or the Company) (TSX:NRI; OTCQX:NRIFF), a Canadian focused, healthcare company with global reach and a diversified portfolio of commercial products, today announced it expects to release its first quarter 2020 financial results before markets open on Monday, May 11, 2020.

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Annual Revenue
Employees
Jesse Ledger's photo - President & CEO of Nuvo Pharmaceuticals

President & CEO

Jesse Ledger

CEO Approval Rating

91/100

Nuvo is a healthcare company that manufactures and commercializes pharmaceutical products for the topical pain relief. Read more